肿瘤微环境内免疫耐受机制研究进展

[11] Potential regulatory function of human dendritic cells expressing indoleamine2,3-dioxygen-ase. Munn DH,Sharma MD,Lee JR,et al. Science . 2002

[12] B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity[J] . Gabriel L Sica,In-Hak Choi,Gefeng Zhu,Koji Tamada,Sheng-Dian Wang,Hideto Tamura,Andrei I Chapoval,Dallas B Flies,Jürgen Bajorath,Lieping Chen. &nbspImmunity . 2003 (6)

[13] Derangement of immune responses by myeloid suppressor cells[J] . Paolo Serafini,Carmela Santo,Ilaria Marigo,Sara Cingarlini,Luigi Dolcetti,Giovanna Gallina,Paola Zanovello,Vincenzo Bronte. &nbspCancer Immunology, Immunotherapy . 2003 (2)

[14] Tumors may modulate host immunity partly through hypoxia-induced sympathetic bias [J]. MEDICAL HYPOTHESES, 2004, 63 (02) : 352 - 356

[15] Studying the immunosuppres-sive role of indoleamine2,3-dioxygenase:tryptophan metabo-lites suppress rat allogeneic T-cell responses in vitro and in vivo. Bauer TM,Jiga LP,Chuang JJ,et al. Transplant International . 2005

[16] Interleukin10(IL-10):an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. Wittke F,Hoffmann R,Buer J,et al. British Journal of Cancer . 1999

[17] Expres-sion of interleukin10in human melanoma. Kruger-Krasagakes S,Krasagakis K,Garbe C,et al. British Journal of Cancer . 1994

[18] Expansion of myeloid im-mune suppressor Gr+CD11b+cells in tumor-bearing host di-rectly promotes tumor angiogenesis. Yang L,DeBusk LM,Fukuda K,et al. Cancer Cell . 2004

[19] Arginase-producing myeloid suppressor cells in renal cell carcinoma patients:a mech-anism of tumor evasion. Zea AH,Rodriguez PC,Atkins MB,et al. Cancer Research . 2005

[20] Gr-1+CD115+immature mye-loid suppressor cells mediate the development of tumor-induced Tregulatory cells and T-cell anergy in tumor-bearing host. Huang B,Pan PY,Li Q,et al. Cancer Research . 2006

[11] Potential regulatory function of human dendritic cells expressing indoleamine2,3-dioxygen-ase. Munn DH,Sharma MD,Lee JR,et al. Science . 2002

[12] B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity[J] . Gabriel L Sica,In-Hak Choi,Gefeng Zhu,Koji Tamada,Sheng-Dian Wang,Hideto Tamura,Andrei I Chapoval,Dallas B Flies,Jürgen Bajorath,Lieping Chen. &nbspImmunity . 2003 (6)

[13] Derangement of immune responses by myeloid suppressor cells[J] . Paolo Serafini,Carmela Santo,Ilaria Marigo,Sara Cingarlini,Luigi Dolcetti,Giovanna Gallina,Paola Zanovello,Vincenzo Bronte. &nbspCancer Immunology, Immunotherapy . 2003 (2)

[14] Tumors may modulate host immunity partly through hypoxia-induced sympathetic bias [J]. MEDICAL HYPOTHESES, 2004, 63 (02) : 352 - 356

[15] Studying the immunosuppres-sive role of indoleamine2,3-dioxygenase:tryptophan metabo-lites suppress rat allogeneic T-cell responses in vitro and in vivo. Bauer TM,Jiga LP,Chuang JJ,et al. Transplant International . 2005

[16] Interleukin10(IL-10):an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. Wittke F,Hoffmann R,Buer J,et al. British Journal of Cancer . 1999

[17] Expres-sion of interleukin10in human melanoma. Kruger-Krasagakes S,Krasagakis K,Garbe C,et al. British Journal of Cancer . 1994

[18] Expansion of myeloid im-mune suppressor Gr+CD11b+cells in tumor-bearing host di-rectly promotes tumor angiogenesis. Yang L,DeBusk LM,Fukuda K,et al. Cancer Cell . 2004

[19] Arginase-producing myeloid suppressor cells in renal cell carcinoma patients:a mech-anism of tumor evasion. Zea AH,Rodriguez PC,Atkins MB,et al. Cancer Research . 2005

[20] Gr-1+CD115+immature mye-loid suppressor cells mediate the development of tumor-induced Tregulatory cells and T-cell anergy in tumor-bearing host. Huang B,Pan PY,Li Q,et al. Cancer Research . 2006